CAMPATH-IH in multiple sclerosis.

類似資料

• Preliminary evidence from magnetic resonance imaging for reduction in disease activity after lymphocyte depletion in multiple sclerosis.
  著者:: Moreau, T, 等
  出版事項: (1994)
• Inflammation, demyelination, and axonal degeneration: Three aspects of the pathogenesis of multiple sclerosis revealed by campath-1H treatment
  著者:: Coles, A, 等
  出版事項: (2003)
• Campath IH allows low-dose cyclosporine monotherapy in 31 cadaveric renal allograft recipients.
  著者:: Calne, R, 等
  出版事項: (1999)
• Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis.
  著者:: Moreau, T, 等
  出版事項: (1996)
• CAMPATH: from concept to clinic.
  著者:: Waldmann, H, 等
  出版事項: (2005)